Moleculin Reports First Quarter 2023 Financial Results

Go back to Moleculin Reports First Quarter 2023 Financial Results
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 1.02 --0 (-0%)
Previous Close $1.02    52 Week High $9.58 
Open $1.02    52 Week Low $2.34 
Day High $1.02    P/E N/A 
Day Low $1.02    EPS $-0.34 
Volume 10,595